India’s Goods Exports Surge Nearly 20% in July Despite Global Uncertainty

New Delhi, August 14, 2026: India’s merchandise exports rose 19.63 per cent year-on-year to $44.24 billion in July 2026, marking a strong recovery in outbound trade despite geopolitical tensions and disruptions affecting global supply chains.

The July performance was supported by strong shipments of petroleum products, electronics and engineering goods. Petroleum exports increased nearly 68 per cent to $6.92 billion, while electronics exports climbed 57.4 per cent to $5.92 billion. Engineering goods shipments grew about 17.7 per cent to $12.24 billion.

India’s exports to West Asia also recovered, rising 8.6 per cent to $5.7 billion during the month. The United States remained the country’s largest export market, with shipments to the US increasing by nearly 13 per cent to $9.02 billion. Exports to China also recorded a sharp rise.

However, the strong export performance was accompanied by a rise in imports. Merchandise imports increased 17.52 per cent to $76.22 billion, pushing the goods trade deficit to a six-month high of $31.98 billion. Higher crude oil prices and increased imports of electronics, gold, fertilisers and coal contributed to the wider deficit.

The July numbers underline the resilience of India’s export sector, while also highlighting the need to strengthen domestic manufacturing, logistics efficiency and supply-chain resilience to sustain growth in global trade.

India’s July Exports Cross $80 Billion as Global Shipments Gain Momentum

New Delhi, August 14, 2026: India’s combined exports of merchandise and services rose 13.31 per cent year-on-year to $80.14 billion in July 2026, signalling continued strength in the country’s external trade despite global economic and geopolitical pressures.

The growth was supported by a sharp rise in merchandise shipments, which climbed 19.6 per cent to a record $44.24 billion during the month. Engineering products, electronics and petroleum-related shipments were among the key contributors to the strong goods export performance.

Services exports also remained an important pillar of India’s trade performance. However, imports of goods and services increased faster, rising 15.83 per cent to $95.16 billion, resulting in an overall trade deficit of about $15.03 billion in July.

The latest figures highlight the resilience of Indian exporters at a time when businesses are dealing with higher freight costs, supply-chain disruptions and geopolitical uncertainty. The strong July performance also adds to the positive momentum recorded during the opening months of FY27.

For policymakers and industry, the challenge now will be to sustain export growth while improving logistics efficiency, widening the export base and containing the impact of rising import costs on the overall trade balance.

NITI Aayog Identifies Four Sectors That Could Drive India’s Manufacturing Ambitions

New Delhi, August 14, 2026: NITI Aayog has identified chemicals, textiles, telecom and networking equipment, and solar photovoltaic (PV) manufacturing as four high-potential sectors that could play a central role in strengthening India’s position in global manufacturing.

The policy think tank’s report focuses on sectors where targeted policy interventions, stronger domestic capabilities and greater value addition can help Indian manufacturers compete more effectively in international markets. The broader exercise covers 12 priority sectors with the objective of increasing India’s participation in global value chains.

NITI Aayog has pointed to opportunities across the four sectors while also highlighting challenges such as import dependence, supply-chain gaps, cost competitiveness and skill shortages. Addressing these constraints will be critical for Indian companies to scale production and move higher up the global value chain.

The report comes as India seeks to raise the contribution of manufacturing to economic growth, exports and employment. NITI Aayog’s approach places greater emphasis on building competitive industrial clusters, improving infrastructure and reducing production costs to attract investment and expand exports.

The recommendations are expected to support India’s longer-term ambition of becoming a major global manufacturing centre by combining domestic demand with export-oriented production and deeper integration into international supply chains.

Centre releasesRs.605.71 Crore to Strengthen Agriculture in Rajasthan and Telangana

New Delhi, August 14, 2026: The Centre has approved a combined allocation of ₹605.71 crore for Rajasthan and Telangana under the Pradhan Mantri Rashtriya Krishi Vikas Yojana (PM-RKVY) and the Krishonnati Yojana, aimed at supporting agricultural development and farmer-focused initiatives.

Rajasthan will receive ₹340.59 crore, while ₹265.12 crore has been approved for Telangana. The decisions followed a review of the states’ annual action plans, utilisation of earlier funds and expenditure progress.

Union Agriculture Minister Shivraj Singh Chouhan approved the allocations during a virtual meeting with Rajasthan Agriculture Minister Kirori Lal Meena and Telangana Agriculture Minister Tummala Nageswara Rao.

Chouhan also appreciated Telangana’s Farmer ID and fertiliser distribution model, highlighting its potential to make the delivery of agricultural services more transparent and efficient. For Rajasthan, he called for greater attention to the implementation of Kisan Credit Cards (KCC) to improve farmers’ access to institutional credit.

The latest funding is expected to support state-level agricultural programmes and strengthen efforts aimed at improving farm productivity, farmer services and rural livelihoods.

SEBI Eyes Wider Accredited Investor Pool With ₹5 Crore Securities Threshold

Mumbai, August 14, 2026: The Securities and Exchange Board of India (SEBI) has proposed a new framework that could make it easier for financially sophisticated investors to qualify as accredited investors, with securities-market holdings emerging as an alternative eligibility criterion.

Under the proposal, an individual with ₹5 crore or more in securities assets could qualify for accredited investor status through this route. SEBI has also suggested a ₹20 crore securities-asset threshold for eligible body corporates and trusts, excluding family trusts.

The proposed changes are aimed at expanding the pool of investors who can participate in products and investment opportunities designed for accredited investors, including certain alternative investment structures. The regulator estimates that the new securities-assets route could potentially bring around 3.7 lakh additional investors into the eligible pool.

SEBI is also looking at making the accreditation process more streamlined. Under the proposed framework, investment managers could be permitted to assess and record an investor’s accredited status as part of the onboarding process.

The move reflects SEBI’s broader effort to make India’s investment ecosystem more accessible to investors with substantial market exposure, while maintaining eligibility standards based on financial capacity and sophistication. The proposals are subject to the regulatory consultation and final approval process.

Project Serotonin Unveils Ready-to-Deploy Preventive Healthcare Platform for Hospitals and Clinics

Bengaluru, Karnataka Aug 14: Project Serotonin (www.projectserotonin.com) announced the launch of its tenth-generation Preventive Health Platform and Precision Health OS, at the recently concluded RISE for Healthy Aging, the Longevity India Conference held at the Indian Institute of Science (IISc), Bengaluru. The Platform is designed to enable large hospitals, multispecialty hospitals, clinic networks, and longevity centers to deliver continuous, personalized preventive care by integrating fragmented health information into actionable precision interventions and measurable outcomes.

Preventive Health Platform & Precision Health OS

Project Serotonin’s Preventive Health Platform offers modular, ready-to-deploy infrastructure to operationalize preventive care at scale. It creates a connective layer that brings diagnostics, genomics, blood biomarkers, wearable data, clinical records, and practitioner insight into one model of care. It helps healthcare institutions move beyond isolated interventions toward a coordinated approach that supports individuals before disease progresses rather than after its onset.

The Platform has been designed to complement existing healthcare infrastructure, not compete with it. Hospitals and clinics continue to practice medicine through their established clinical pathways, while Project Serotonin adds a structured prevention layer supporting risk stratification, protocol design, patient engagement, monitoring, and behavior change, without asking clinicians to change how they practice or hospitals to trade treatment revenue for prevention.

The need for change has become increasingly evident. According to the World Health Organization, non-communicable diseases account for nearly 75 percent of all deaths globally. In India, where non-communicable diseases often present three to ten years earlier than in developed nations and multimorbidity has increased dramatically over the past three decades, a recent EY–FICCI assessment concluded that appropriate preventive interventions could reduce hospitalizations by 20 to 30 percent.

Advances in genomics, blood biomarkers, imaging, wearable technologies, and artificial intelligence have significantly expanded the volume and diversity of health information available to clinicians. Yet most healthcare institutions continue to use these datasets in isolation, limiting their ability to build a longitudinal understanding of an individual’s health and leaving preventive care fragmented and difficult to scale.

At the core of the Platform is Project Serotonin’s proprietary Precision Health OS, an orchestration engine that evaluates each individual’s genetic predispositions, biomarker trajectories, wearable trends, lifestyle patterns, pharmacogenetic considerations, and clinical history as one unified health profile. The Precision Health OS incorporates safeguards for contraindications, interactions, and escalation pathways, alongside anonymization, encryption, and role-based access controls.

This intelligence is translated into the SRTN Precision Daily Operating System (SRTN-pDOS), an individualized care framework that converts complex biological information into structured, practitioner-guided protocols across two care formats: foundational preventive care and therapy-adjunct protocols addressing specific health areas such as gut and cardiovascular health.

These SRTN precision protocols draw on an evidence base of more than 44,000 stratified clinical studies and have been refined through real-world pilots. They span nutrition, supplementation, physical activity, sleep, stress management, and other modifiable health behaviors. Recommendations are delivered through the SRTN App and supported by care concierge teams and health coaches who help individuals sustain adherence over time. WHO evidence has documented adherence rates as low as 28 percent for some regular preventive therapies in developed countries, underscoring the challenge of sustaining long-term engagement. Project Serotonin’s engagement architecture is designed to address this gap.

“We are at an inflection point in human health. Project Serotonin is built for the Medicine 4.0 era, which is defined not by how much data we collect, but by how intelligently we connect it,” said Dr Ashwat Visvanathan (PhD), Head – Partnerships and User Outcomes, Project Serotonin. “Healthcare has invested heavily in digitizing records and expanding diagnostics. The next frontier is enabling a continuous understanding of every individual. We built Project Serotonin to help healthcare providers move from episodic treatment to plug-and-play precision prevention, without disrupting the systems and clinical expertise they already have.”

The Platform connects twelve integrated systems that have traditionally functioned in isolation, from diagnostics, genomics, and wearable intelligence to a clinician console, Rx Intelligence screened against more than 2,600 drugs, patient engagement, fulfillment, adherence coaching, and operational management. Institutions can deploy the complete Platform or adopt modular capabilities, determining their own pace and scope of adoption.